Search results

Found 398 pages
AUTHOR: George Underwood

Results per page

10 20 50 100

Sort by

Relevance Date

6 Oct 2017:

Bayer halts Xarelto trial

Trial was evaluating the drug in patients with embolic stroke of undetermined source (ESUS). - News - PharmaTimes

by George Underwood

www.pharmatimes.com/news/bayer_halts_xarelto_trial_1207036

4 Jan 2016:

Shire and Baxalta near deal

Shire is reportedly in advanced talks to acquire Baxter's biopharma spin-off Baxalta and may announce a deal this week. - News - PharmaTimes

by George Underwood

www.pharmatimes.com/news/shire_and_baxalta_near_deal_1020698

24 Oct 2018:

Medidata teams with Pharm-Olam

CRO hopes partnership will accelerate drugs' time to market - News - PharmaTimes

by George Underwood

www.pharmatimes.com/news/medidata_teams_with_pharm-olam_1256852

24 May 2016:

Lansons recruits Kate Aldous

Appointment boosts healthcare offering - Appointments - PharmaTimes

by George Underwood

www.pharmatimes.com/appointments/lansons_recruits_kate_aldous_1029021

5 Sep 2017:

Method Medical Media launches

London-based agency begins trading today - News - PharmaTimes

by George Underwood

www.pharmatimes.com/news/method_medical_media_launches_1204334

3 Oct 2017:

'Universal' flu vaccine to be tested

Vaccine uses T-cells to potentially attack multiple strains of the virus - News - PharmaTimes

by George Underwood

www.pharmatimes.com/news/universal_flu_vaccine_to_be_tested_1206771

14 Jun 2017:

New general manager for Abbie UK

- Appointments - PharmaTimes

by George Underwood

www.pharmatimes.com/appointments/new_general_manager_for_abbie_uk_1195687

12 Sep 2017:

Humira gets EC approval for anterior uveitis

Humira is now the only EU biologic treatment option for children with the disease - News - PharmaTimes

by George Underwood

www.pharmatimes.com/news/humira_gets_ec_approval_for_anterior_uveitis_1205082

1 May 2018:

FDA grants Keytruda priority review

If approved by the FDA, this would mark the third indication for Keytruda in metastatic NSCLC in the United States based on OS data - News - PharmaTimes

by George Underwood

www.pharmatimes.com/news/fda_grants_keytruda_priority_review_1233852

26 Sep 2017:

EC approves Janssen’s Symtuza

Drug is only darunavir-based STR indicated for HIV-1 infection in adults and adolescents - News - PharmaTimes

by George Underwood

www.pharmatimes.com/news/ec_approves_janssens_symtuza_1206421